Skip to main content
OpenTrials
Completed

NCT Number: NCT01128374

The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) has become a significant pandemic with more than 7% of the population in the United States affected. Moreover, up to one-third of these individuals may not be aware of the diagnosis and, are not involved in treatment. In the Mexican-American population, prevalence rates may be up to 50%. Contributing factors such as poor education, low household income, language barriers and restricted access to medical services may increase this prevalence. The association between periodontal disease and diabetes has been well documented; however, interventional studies have resulted in conflicting conclusions on improvements in glycemic control following periodontal therapy.

Diabetes and periodontal disease share common pathways in pathogenesis, such as their polygenic nature and immunoregulatory dysfunction. To answer these questions, we, the investigators, propose this randomized controlled trial designed to elucidate how treatment of periodontal disease can be used for preventive and therapeutic purposes in a diabetic population as well as to study the role of IL-1 gene cluster polymorphisms as a risk factor for the presence of periodontitis in a Hispanic T2DM population. Our central hypothesis is that the Mexican-American T2DM population in Texas is at risk for an increased presence and severity of periodontal disease due to the presence of Il-1 gene cluster polymorphisms; furthermore we suggest that providing non-surgical periodontal therapy to this group will decrease the bacterial load associated with disease and as a consequence, will improve glycemic control as measured by HbA1c values. Our long-term goal is to study risk factors associated with the presence of periodontal disease and to understand how the treatment of periodontal disease can be used for preventive and therapeutic purposes in a Hispanic type 2 diabetic population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Mouth Diseases Nutritional and Metabolic Diseases Periodontal Disease Periodontal Diseases Stomatognathic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas Health Science Center Houston, Dental Branch

Houston, Texas, 77030, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years old
  • Diagnosed type 2 diabetes mellitus
  • Existence of moderate to severe periodontitis as defined by the American Academy of Periodontology
  • In good general health - able to undergo the proposed therapy without compromise to existing health
  • Demonstrated ability to read and understand written Spanish or English without the aid of ad-hoc interpretation by a third party
  • Demonstrated ability to understand the proposed therapy and possible outcome
  • Demonstrated willingness to comply with all protocol requirements as outlined in the informed consent document
  • Willingness/ability to sign an informed consent document for their own inclusion in the study
  • Hispanic origin as confirmed by patient records

Exclusion criteria

  • Pregnancy at the time of enrollment (Pregnancy test is required for female study participants of child-bearing potential.)
  • Use of antibiotics within last 3 months
  • Immunocompromised health status
  • Other medical conditions that represent a threat to life
  • Osteoporosis
  • Biphosphonates, corticosteroids or behavior alteration medications
  • Historical abuse of alcohol or drugs
  • Use of cigarettes/tobacco products within the past 12 months
  • Mental diseases
  • Any other oral pathology that compromise the patient's medical status
  • Diagnosed type 1 diabetes mellitus (Information will be obtained from the medical records)

Treatment and study plan

Periodontal Scaling and Root Planing

Procedure

Participants will be instructed to brush their teeth using the modified Bass toothbrushing technique; the use of interproximal hygiene aids such as proximal brush or dental floss will be included. A full mouth scaling and root planning will be performed in 2 appointments (2 hours each) with the use of local anesthesia (typically 2% lidocaine with 1:100,000 epinephrine). In the control group, this treatment will be performed after all the data and samples have been collected and will encompass the last 2visits. Periodontal scaling and root planning treatment has been defined by The American Academy of Periodontology (AAP) as the standard of care for patients with periodontal disease. An ultrasonic instrument, scalers and curettes will be utilized to remove calculus and obtain a smooth root surface. The experimental subjects will be appointed 1 week later to complete the scaling and root planning procedure

Primary outcomes

  1. HbA1c percentage

    Time frame: At baseline and 120 days after treatment

Secondary outcomes

  1. microbial burden

    Time frame: Baseline and 120 days after therapy

  2. gene polymorphisms

    Time frame: 120 days after enrolment

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Collaborators

  • University of Alabama at Birmingham

Registry information

Official study title

The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 DiabetesS

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
May 21, 2010
Registry last updated
Jan 15, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.